Reprogram Biosciences
PrivateLast Round
Seed
May 27, 2026
Total Funding Raised
$6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Reprogram Biosciences is a biotechnology company that develops mRNA-based therapeutics that reprogram tumor cells to activate the immune system, with a focus on treating solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reprogram Biosciences Comparables
Compare Reprogram Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asgard Therapeutics | 81% | |
| CREATE Medicines | 77% | |
| Eli Lilly and Company | 77% |
Reprogram Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 27, 2026 |
Key People
Founding team and executive leadership
Reprogram Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Narya Capital | Seed |
| 1517 Fund | Seed |
| Unshackled Ventures | Seed |
| Narya | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$6M raised from 1517 Fund, Narya, and Unshackled Ventures.
Reprogram Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Reprogram Biosciences's valuation, stock price, and market status.
Is Reprogram Biosciences a public or private company?
Reprogram Biosciences is a private company.
What is the current stock price of Reprogram Biosciences?
Reprogram Biosciences is a private company, so its shares have no public market price. Caplight tracks Reprogram Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reprogram Biosciences worth (valuation)?
Valuation information for Reprogram Biosciences is not publicly available.
Can I buy Reprogram Biosciences stock?
Reprogram Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reprogram Biosciences's last funding round?
Reprogram Biosciences's most recent funding round was Seed on May 27, 2026.
Who are the main investors in Reprogram Biosciences?
Key investors in Reprogram Biosciences include Narya Capital, 1517 Fund, Unshackled Ventures, Narya.
Will Reprogram Biosciences IPO soon?
No public IPO plans have been announced for Reprogram Biosciences.
How can I track Reprogram Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Reprogram Biosciences's shares on secondary markets.